CN1172690C - Chinese medicine powder for treating tetanic rachitis - Google Patents

Chinese medicine powder for treating tetanic rachitis Download PDF

Info

Publication number
CN1172690C
CN1172690C CNB001213806A CN00121380A CN1172690C CN 1172690 C CN1172690 C CN 1172690C CN B001213806 A CNB001213806 A CN B001213806A CN 00121380 A CN00121380 A CN 00121380A CN 1172690 C CN1172690 C CN 1172690C
Authority
CN
China
Prior art keywords
radix
parts
rhizoma
root
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001213806A
Other languages
Chinese (zh)
Other versions
CN1335147A (en
Inventor
豪 郭
郭豪
郭德荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001213806A priority Critical patent/CN1172690C/en
Publication of CN1335147A publication Critical patent/CN1335147A/en
Application granted granted Critical
Publication of CN1172690C publication Critical patent/CN1172690C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a pure traditional Chinese medicine powder for treating ankylosing spondylitis, which is prepared from the raw materials of the following proportion(proportion by weight): 1.6 to 2.4 of salvia miltiorrhiza, 0.8 to 1.2 of cassia twig, 0.8 to 1.2 of notopterygium root, 0.8 to 1.2 of ledebouriella root, 1.6 to 2.4 of pueraria root, 0.8 to 1.2 of angelicae pubescentis, 0.8 to 1.2 of clematis root, 0.8 to 1.2 of manchurian wildginger, 0.8 to 1.2 of suberect spatholobus stem, 0.6 to 2.4 of sinomenium acutum, 1.6 to 2.4 of gentianae macrophyllae, 1.6 to 2.4 of orientvine stem, 1.6 to 2.4 of common clubmoss herb, 1.6 to 2.4 of white peony root, 1.6 to 2.4 of cibot rhizome, 0.8 to 1.2 of atractylodes rhizome, 0.8 to 1.2 of tripterygium wilfordii and 0.8 to 1.2 of licorice.

Description

The Chinese powder medicine that is used for the treatment of ankylosing spondylitis
Technical field
The present invention relates to a kind of Chinese medicine medicine for external use that is used for the treatment of ankylosing spondylitis, belong to Chinese medicine topical agent field.
Background technology
Ankylosing spondylitis (being called for short AS) (Anky Losing Spondy Lifis) is to invade axis joint and the big joint of extremity, and often relate to other joint and internal organs, can cause human body deformity and maimed, be a kind of carrying out property, independence, systemic disease, so become the disease of serious harm human body health.At present, ankylosing spondylitis is acknowledged as connective tissue seronegativity disease, it is characterized in that from sacroiliac joint, and up gradually spreading to joint of vertebral column caused the bony ankylosis deformity, and this disease sickness rate accounts for entire population's 0.3%, is more common in young male.This disease early diagnosis difficulty, the anaphase difficulty, though there is not the danger of life, disability rate is worldwide difficult osteopathia up to 80%, the someone is referred to as " second cancer ", " not dead cancer ".At present, still there be not good method and the effective medicine of specially controlling this disease both at home and abroad.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine medicine for external use powder that effectively is used for the treatment of ankylosing spondylitis.
Chinese powder medicine of the present invention is made up of the component of following weight proportion:
Radix Salviae Miltiorrhizae 1.6-2.4 part Ramulus Cinnamomi 0.8-1.2 part Rhizoma Et Radix Notopterygii 0.8-1.2 part Radix Saposhnikoviae 0.8-1.2 part
Radix Puerariae 1.6-2.4 part Radix Angelicae Pubescentis 0.8-1.2 part Radix Clematidis 0.8-1.2 part Herba Asari 0.8-1.2 part
Caulis Spatholobi 0.8-1.2 part Radix Stephaniae Tetrandrae 0.6-2.4 part Radix Gentianae Macrophyllae 1.6-2.4 part Caulis Sinomenii 1.6-2.4 part
Herba Lycopodii 1.6-2.4 part Radix Paeoniae Alba 1.6-2.4 part Rhizoma Cibotii 1.6-2.4 part Rhizoma Atractylodis 0.8-1.2 part
Radix Tripterygii Wilfordii 0.8-1.2 part Radix Glycyrrhizae 0.8-1.2 part.
This kind powder can be made up of the component of following weight proportion:
1 part of 1 part of Radix Saposhnikoviae of 1 portion of Rhizoma Et Radix Notopterygii of 2 parts of Ramulus Cinnamomi of Radix Salviae Miltiorrhizae
1 part of 1 part of Herba Asari of 1 part of Radix Clematidis of 2 parts of Radix Angelicae Pubescentiss of Radix Puerariae
2 parts of 2 parts of Caulis Sinomeniis of 2 portions of Radix Gentianae Macrophyllae of 1 part of Radix Stephaniae Tetrandrae of Caulis Spatholobi
1 part of 2 parts of Rhizoma Atractylodis of 2 parts of Rhizoma Cibotii of 2 portions of Radix Paeoniae Albas of Herba Lycopodii
1 part in 1 portion of Radix Glycyrrhizae of Radix Tripterygii Wilfordii.
The compound method of this powder is: every flavor medicine is put together in required ratio and weight, be broken into planar through pulverizer, sterilize by disinfection cabinet then, put into cloth bag again, every bag of 120g is during application, use 100g vinegar for every bag, mix medicated powder thoroughly, put into cooking-vessel and be heated to 40-50 ℃, be placed on patient's spinal column both sides then.2-3 time on the one, 2 months is a course of treatment.
Motherland's medical science thinks that the pathogeny of ankylosing spondylitis is: on hereditary basis, and the damaged of holding concurrently, infection, the injury of some inflammation pathogenic bacterium causes unusual immunoreation and falls ill.Its pathological change, the natural endowment deficiency will be lost in taking good care of the day after tomorrow, make the kidney essense inanition, the kidney pulse loses and to fill, the excessive QI resistance is closed, the QI and blood impatency, podomere is lost moisten foster, withering useless distortion.
This powder preferably has the adjusting immunologic function, promote tissue regeneration and repair function, and tens flavor Chinese medicines of analgesic, analgesia, pain relieving, sterilization, anti-inflammatory properties to carry out reasonable compatibility formulated, share total expelling wind and removing dampness, the analgesic therapy of invigorating blood circulation, dredge the merit of superintending and directing collateral dredging, nourishing the liver and kidney.Clinical practice proves: Chinese powder medicine good effect of the present invention, and expense is low, short treating period, patient's no pain has improved the healing and the improvement rate of ankylosing spondylitis greatly, and impetus has energetically been played in the treatment of ankylosing spondylitis.
The specific embodiment
Prove the curative effect of Chinese powder medicine of the present invention below by clinical application effect:
Experimental group 220 examples, matched group 30 examples.In experimental group 220 examples, male 180 examples, women 40 examples, wherein early stage 84 examples, mid-terms 98 example, later stages 38 example.In the matched group, male 21 examples, women 9 examples, wherein early stage 10 examples, mid-terms 15 example, late periods 5 example.Experimental group one rate is with Chinese powder medicine external application of the present invention, per two months courses of treatment, the case for the treatment of the shortest 2 courses of treatment, the longest 10 courses of treatment, average 6.5 courses of treatment.As a result, experimental group 118 examples of fully recovering account for 53.64%, and effective percentage accounts for 95.6%, and inefficiency accounts for 4.4%.Matched group 30 examples, 6 examples are cured in treatment routinely, effective 24 examples, invalid 6 examples account for 20%, 80%, 20% respectively.Experimental group obviously is better than matched group.
Embodiment
1 part of 1 part of Radix Saposhnikoviae of 1 portion of Rhizoma Et Radix Notopterygii of 2 parts of Ramulus Cinnamomi of Radix Salviae Miltiorrhizae
1 part of 1 part of Herba Asari of 1 part of Radix Clematidis of 2 parts of Radix Angelicae Pubescentiss of Radix Puerariae
2 parts of 2 parts of Caulis Sinomeniis of 2 portions of Radix Gentianae Macrophyllae of 1 part of Radix Stephaniae Tetrandrae of Caulis Spatholobi
1 part of 2 parts of Rhizoma Atractylodis of 2 parts of Rhizoma Cibotii of 2 portions of Radix Paeoniae Albas of Herba Lycopodii
1 part in 1 portion of Radix Glycyrrhizae of Radix Tripterygii Wilfordii.
The compound method of this powder is: every flavor medicine is put together in required ratio and weight, be broken into planar through pulverizer, sterilize by disinfection cabinet then, put into cloth bag again, every bag of 120g is during application, use 100g vinegar for every bag, mix medicated powder thoroughly, put into cooking-vessel and be heated to 40-50 ℃, be placed on patient's spinal column both sides then.2-3 time on the one, 2 months courses of treatment.

Claims (2)

1, a kind of Chinese powder medicine that is used for the treatment of ankylosing spondylitis, it is characterized in that: it is made up of the component of following weight proportion:
Radix Salviae Miltiorrhizae 1.6-2.4 part Ramulus Cinnamomi 0.8-1.2 part Rhizoma Et Radix Notopterygii 0.8-1.2 part Radix Saposhnikoviae 0.8-1.2 part
Radix Puerariae 1.6-2.4 part Radix Angelicae Pubescentis 0.8-1.2 part Radix Clematidis 0.8-1.2 part Herba Asari 0.8-1.2 part
Caulis Spatholobi 0.8-1.2 part Radix Stephaniae Tetrandrae 0.6-2.4 part Radix Gentianae Macrophyllae 1.6-2.4 part Caulis Sinomenii 1.6-2.4 part
Herba Lycopodii 1.6-2.4 part Radix Paeoniae Alba 1.6-2.4 part Rhizoma Cibotii 1.6-2.4 part Rhizoma Atractylodis 0.8-1.2 part
Radix Tripterygii Wilfordii 0.8-1.2 part Radix Glycyrrhizae 0.8-1.2 part.
2, Chinese powder medicine according to claim 1 is characterized in that: it is made up of the component of following weight proportion:
1 part of 1 part of Radix Saposhnikoviae of 1 portion of Rhizoma Et Radix Notopterygii of 2 parts of Ramulus Cinnamomi of Radix Salviae Miltiorrhizae
1 part of 1 part of Herba Asari of 1 part of Radix Clematidis of 2 parts of Radix Angelicae Pubescentiss of Radix Puerariae
2 parts of 2 parts of Caulis Sinomeniis of 2 portions of Radix Gentianae Macrophyllae of 1 part of Radix Stephaniae Tetrandrae of Caulis Spatholobi
1 part of 2 parts of Rhizoma Atractylodis of 2 parts of Rhizoma Cibotii of 2 portions of Radix Paeoniae Albas of Herba Lycopodii
1 part in 1 portion of Radix Glycyrrhizae of Radix Tripterygii Wilfordii.
CNB001213806A 2000-07-26 2000-07-26 Chinese medicine powder for treating tetanic rachitis Expired - Fee Related CN1172690C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001213806A CN1172690C (en) 2000-07-26 2000-07-26 Chinese medicine powder for treating tetanic rachitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001213806A CN1172690C (en) 2000-07-26 2000-07-26 Chinese medicine powder for treating tetanic rachitis

Publications (2)

Publication Number Publication Date
CN1335147A CN1335147A (en) 2002-02-13
CN1172690C true CN1172690C (en) 2004-10-27

Family

ID=4588763

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001213806A Expired - Fee Related CN1172690C (en) 2000-07-26 2000-07-26 Chinese medicine powder for treating tetanic rachitis

Country Status (1)

Country Link
CN (1) CN1172690C (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301729C (en) * 2003-10-21 2007-02-28 中国人民解放军总医院 Medicine for treating tetanic rachitis and its prepn process
CN100394947C (en) * 2004-12-29 2008-06-18 承德颈复康药业集团有限公司 Medicinal composition for treating cervical vertebra disease and its preparation method
CN101040927B (en) * 2007-04-19 2010-05-26 尹继君 Chinese traditional medicine compound took orally for treating ankylosing spondylitis
CN102657736B (en) * 2012-05-28 2014-03-05 石家庄平安医院有限公司 Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition
CN103751272B (en) * 2014-02-21 2017-08-04 中国人民解放军第三军医大学第二附属医院 Treat the Chinese medicine composition and its extract of ankylosing spondylitis
CN103893427A (en) * 2014-04-15 2014-07-02 韩世昌 Traditional Chinese medicine composition for treating ankylosing spondylitis and preparation method thereof
CN103977308A (en) * 2014-05-16 2014-08-13 刘高志 Tradition Chinese medicine composition for treating ankylosing spondylitis
CN109663080A (en) * 2017-10-17 2019-04-23 张猛 A kind of smoked medicament and its application method for washing ankylosing spondylitis
CN109985223A (en) * 2019-04-10 2019-07-09 舟山市顾氏倪诚股骨头疾病研究所 A kind of wind-damp dispelling cream

Also Published As

Publication number Publication date
CN1335147A (en) 2002-02-13

Similar Documents

Publication Publication Date Title
CN101167847B (en) Traditional Chinese medicinal white spirit preparation for effectively treating skin disease
CN1686191A (en) Anticommon cold Chinese medicine breathing mask
CN1966003A (en) Externally applied medicament for treating rheumatism
CN1172690C (en) Chinese medicine powder for treating tetanic rachitis
CN1135909A (en) Medicine for hyperosteogeny and wind-cold syndrome
CN1067571C (en) Chinese medicine capsule for treating lumbar and cervical protrusion
CN100340284C (en) Jindan gallbladder stone dissolving capsule
CN1312085A (en) Dermatosis treating medicine
CN105327244A (en) Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating bedsores and preparing method thereof
CN105853866A (en) Method for preparing Chinese herbal medicine composition for treating bedsore
CN104800443A (en) Bone setting agent with functions of tonifying kidney and regenerating bone marrow
CN1203804A (en) Ganbingkang medicine for curing liver disease
CN115990232B (en) Traditional Chinese medicine composition for treating recurrent urinary tract infection and application thereof
CN1087618C (en) Medicine for treating allergic rhinitis
CN1485086A (en) Peroral Chinese medicine powder for treating bone fracture and its preparing process
CN1277559C (en) Medicine for treating rheumatism and its preparation
CN1180808C (en) Chinese medicine for treating rheumatic and rheumatoid diseases
CN1235627C (en) Oral adminitration Chinese medicine for treating lung cancer
CN1839774A (en) Thermotherapy bag for treating galactophore hyperplasia
CN105560893A (en) Traditional Chinese medicine composition for treating periodontitis
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer
CN104888076A (en) Traditional Chinese medicine preparation for treating tooth decay
CN104922476A (en) Drug for treating gingivitis
CN104887917A (en) Traditional Chinese medicine for treating periodontitis
CN1259940C (en) Medicinal composition for treatnig bone fracture

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee